Table:
begin	end	state
1	20	cytoplasmic
21	42	transmembrane
43	61	non-cytoplasmic
62	83	transmembrane
84	94	cytoplasmic
95	115	transmembrane
116	120	non-cytoplasmic
121	141	transmembrane
142	161	cytoplasmic
162	182	transmembrane
183	202	non-cytoplasmic
203	222	transmembrane
223	270	cytoplasmic
271	291	transmembrane
292	315	non-cytoplasmic
316	337	transmembrane
338	343	cytoplasmic
344	360	transmembrane
361	365	non-cytoplasmic
366	387	transmembrane
388	398	cytoplasmic
399	422	transmembrane
423	433	non-cytoplasmic
434	453	transmembrane
454	472	cytoplasmic

Input:
>WP_103231791.1 NCBI__GCF_002899945.2:WP_103231791.1
MAEMAGKYDKGVLGRRKKPNLSMLQIINMSMGFLGIQMAFGLQNGNASRILGNLGADVHE
LSWFWLVAPVTGLIVQPIIGHMGDNTWSPLGRRKPYFLIGAVLCAVGLVLLPNAASVTQM
FAANALLLAVIFLAMMDASVNIAMEPFRALVGDMLPKHQGTIGFSVQTILIGIGAVLGSY
LPDWLTKIGISNEAPQGFVADNVIYSFYIGAGLLIISILYTIMTTREYSPQEFAEFEDEK
EAEKHESKFSDIFKDFASIPVQMKKLGIVQFFSWFALFTMWVFTTSALATHHLGLSPEDT
HSKAFNDAGDLTGKLFGMYNLWAIPFAFLLTPIAKLIGKKQTHALALLCGGLGLISMYFI
KEVDHLWISMIGLGFAWASILAMPYAMLIDVIPQRKMGVYMGIFNFFIVIPQIINGLFGG
PIVSGIFGKQAMDYVVVGGVCMLIGAVVTMIFVKSEDETPKEIEDEIKQVHF

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server